Abstract
We prospectively determined the prevalence of morbidity from the various forms of diabetic neuropathy over one year in a population of 800 patients with diabetes mellitus (336 type 1, 464 type 2 DM). Symptoms documented were: pain/paraesthesia in the feet, loss of feeling and the restless legs syndrome. We also documented the prevalence of: neuropathic ulcers, amyotrophy, foot drop, and oculomotor palsy. Autonomic symptoms documented were: impotence, postural hypotension and diarrhoea. The only symptoms reported by 100 non-diabetic control subjects were: loss of feeling in 2% and restless legs syndrome in 7%. In the diabetics; pain/paraesthesia was present in 13%, feeling loss in 7% and neuropathic ulcers in 2%. The prevalence of Diabetic amyotrophy (proximal femoral neuropathy) was 0.8%, oculomotor palsy 0.1% and peroneal nerve palsy 0.1%. Erectile impotence was present in 20%, symptomatic postural hypotension in 1% and diabetic diarrhoea in 1%. Overall; 22.9% of the population was afflicted by one or more problems resulting from neuropathy. Neuropathy was associated with older age (p < 0.001), and serious retinopathy (p < 0.001) in both groups of diabetics and with duration of diabetes, proteinuria (p < 0.02), hypertension (p < 0.01) and ischaemic heart disease (p < 0.02) in type 1 diabetics.
Similar content being viewed by others
References
Vinik, A. 1., Liuzzi, F. J., Holland, M. T., Stanberry, K. B., Le Beau, J. M., Colen, L. B. Diabetic Neuropathies. Diabetes Care 1992; 15: 1926–1967.
Pirart, J. Diabetes mellitus and its degenerative complications: prospective study of 4400 patients observed between 1947 and 1973 (Part2). Diabet. Metab. 1977; 3: 173–82.
Mayne, N. Neuropathy in the diabetic and non-diabetic populations. Lancet 1965; ii: 1313–15.
Boulton, A. J., Knight, G., Drury, J., Ward, J. The prevalence of symptomatic, diabetic neuropathy in an insulin treated population. Diabetes Care 1985; 8: 125–128.
Ziegler, D., Gries, F. A., Spuler, M., Lessman, F. The Epidemiology of Diabetic Neuropathy. Journal of Diabetes Complications 1992; 6: 4957.
Franklin, G. M., Kahn, L. B., Baxter, J. Marshall, Hamman, R. F. Sensory neuropathy in non-insulin dependent diabetes mellitus. Amer. J. Epidemiol. 1990; 131: 633–643.
Maser, R. E., Steenkiste, R. A., Dorman, J. S. et al. Epidemiological correlates of diabetic neuropathy. Diabetes 1989 38: 1456–61.
Walters, D. P., Gatling, W., Mullee, M. A., Hill, R. D. The prevalence of diabetic sensory neuropathy in an English community. Diabetic Medicine. 1992; 9: 349–53.
Watkins, P. J. Clinical observations and experiments in diabetic neuropathy. Diabetologia 1992; 35: 2–11.
Haimanot, R. T. amd Abdulkadir, J. Neuropathy in the Etheopian diabetic: a correlation between clinical and nerve conduction studies. Trop. Geougr. Med. 1985; 37: 66–68.
Coppack, S. W. and Watkins, P. J. The natural history of diabetic femoral neuropathy. Q. J. Med. 1991; 79: 307–13.
Walton, J. Some miscellaneous disorders of muscle: Restless Legs syndrome. In Brain: Diseases of the Nervous System. Edited by Walton, J. W. Oxford Medical Publications. Eight Edition. Oxford 1977, 1049–50.
Stewart, J. D. Diabetic truncal neuropathy, topography of the sensory deficit. Ann. Neurol. 1989; 25: 233–38.
Feldman, M., Schiller, L. R. Disorders of gastrointestinal motility associated with diabetes mellitus. Annal. of Intern. Med. 1983; 98: 378–84.
Yang, R., Arem, R., Chan, L. Gastrointestinal tract complications of diabetes mellitus. Arch. Intern. Med. 1984; 144: 1251–56.
Bennet, P. Classification and diagnosis of diabetes mellitus and impaired glucose intolerance. In: Textbook of Diabetes. Edited by Pickup, J. C. and Williams, G. Blackwell Scientific Publications, Oxford. 1991: 37–46.
Dyck, P. J. Detection, characterisation and staging of polyneuropathy assessed in diabetes. Muscle and Nerve 1988; 11: 21–31.
Green, D. A., Brown, M. J., Braunstein, S. N., Schwartz, S. S., Ashbury, A. K. and Winegrad, A. I. Comparison of clinical course and sequential electrophysiological tests in diabetics with symptomatic polyneuropathy and its implications for clinical trials. Diabetes 1981; 30: 139–47.
Cohen, D. L., Neil, H. A. W., Thorogood, M. and Mann, J. I. A population based study of the incidence of complications associated with type 2 diabetes in the elderly. Diabetic Medicine 1991; 8: 928–33.
Bilous, R.W. (Editorial). Diabetic autonomic neuropathy. BMJ 1990; 301: 565–6.
Neil, H. A., Thompson, A. V., John, S., McCarthy, S. T. and Mann, J. I. Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population. Diab. Med. 1989; 6: 20–24.
Guirguis, W. R. Impotence in Diabetes: facts and fictions. Diab. Med. 1992; 11: 287–89.
Harriss, M. I., Klein, R., Welborn, T. A., Knuiman, M. W. Onset of NIDDM occurs at least 4–7 years before clinical diagnosis. Diabetes Care 1992; 15: 815–19.
Said, G., Goulan-Goeau, C., Slama, G., Tchoroutsky, G. Severe early-onset polyneuropathy in insulin dependent diabetes mellitus. N. Engl. J. Med. 1992; 326: 1257–63.
Mogensen, C. E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N. Eng. J. Med. 1984; 310: 356–60.
Rabinowe, S. L. Immunology of diabetic and polyglandular neuropathy. Diabetes/Metabolism Revws. 1990; 6: 169–88
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O’Hare, J.A., Abuaisha, F. & Geoghegan, M. Prevalence and forms of neuropathic morbidity in 800 diabetics. I.J.M.S. 163, 132–135 (1994). https://doi.org/10.1007/BF02965972
Issue Date:
DOI: https://doi.org/10.1007/BF02965972